Negative effect of paraskeletal plasmacytoma on survival of patients with transplant-ineligible newly diagnosed multiple myeloma

被引:0
作者
Junzhe Wang
Xiaoning Song
Xian Zhang
Han Liu
Meirong Zang
Dianwen Qi
Jinqiao Zhang
Lixia Sun
机构
[1] Hebei Medical University Third Hospital,Department of Hematology
[2] Hebei Medical University Third Hospital,Department of Bone and Soft Tissue Oncology
来源
Annals of Hematology | 2024年 / 103卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1411 / 1414
页数:3
相关论文
共 50 条
  • [31] Practice Patterns in Front-line Treatment of Transplant-Eligible and Transplant-Ineligible Newly Diagnosed Multiple Myeloma
    Poy, Theprungsirikul
    Liu Yuxin
    Natalia, Neparidze
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S28 - S28
  • [32] Ixazomib maintenance in transplant-ineligible patients with newly diagnosed multiple myeloma: final overall survival analysis from the TOURMALINE-MM4 study
    Dimopoulos, Meletios
    Chng, Wee Joo
    Iida, Shinsuke
    Mateos, Maria-Victoria
    Morgan, Gareth
    Lonial, Sagar
    Spicka, Ivan
    Quach, Hang
    Oriol, Albert
    Hajek, Roman
    Garg, Mamta
    Giuliani, Nicola
    Beksac, Meral
    Katodritou, Eirini
    Bringhen, Sara
    Li, Cong
    Zhang, Xiaoquan
    Labotka, Richard
    Rajkumar, Vincent
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S95 - S95
  • [33] Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Overall Survival in Alcyone
    Mateos, Maria-Victoria
    Cavo, Michele
    Blade, Joan
    Dimopoulos, Meletios A.
    Suzuki, Kenshi
    Jakubowiak, Andrzej
    Knop, Stefan
    Doyen, Chantal
    Lucio, Paulo
    Nagy, Zsolt
    Pour, Ludek
    Cook, Mark
    Grosicki, Sebastian
    Crepaldi, Andre H.
    Liberati, Anna Marina
    Campbell, Philip
    Shelekhova, Tatiana
    Yoon, Sung-Soo
    Iosava, Genadi
    Fujisaki, Tomoaki
    Garg, Mamta
    Krevvata, Maria
    Wang, Jianping
    Kudva, Anupa
    Ukropec, Jon
    Wroblewski, Susan
    Kobos, Rachel
    San-Miguel, Jesus
    [J]. BLOOD, 2019, 134
  • [34] Clinical consensus on treatments for transplant-ineligible newly diagnosed multiple myeloma: double-blinded Delphi panel
    Fonseca, Rafael
    Rossi, Adriana
    Medhekar, Rohan
    Voelker, Jennifer
    Homan, Trevor
    Wilcock, Jessica
    Karakusevic, Anna
    Cochrane, James
    Bridge, Daisy
    Perry, Richard
    Kaila, Shuchita
    Davies, Faith E.
    [J]. FUTURE ONCOLOGY, 2024, 20 (23) : 1645 - 1656
  • [35] Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma
    Jakubowiak, Andrzej J.
    Kumar, Shaji
    Medhekar, Rohan
    Pei, Huiling
    Lefebvre, Patrick
    Kaila, Shuchita
    He, Jianming
    Lafeuille, Marie-Helene
    Cortoos, Annelore
    Londhe, Anil
    Mavros, Panagiotis
    Lin, Thomas S.
    Usmani, Saad Z.
    [J]. ONCOLOGIST, 2022, 27 (07) : E589 - E596
  • [36] Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
    Facon, Thierry
    Cook, Gordon
    Usmani, Saad Z.
    Hulin, Cyrille
    Kumar, Shaji
    Plesner, Torben
    Touzeau, Cyrille
    Bahlis, Nizar J.
    Basu, Supratik
    Nahi, Hareth
    Goldschmidt, Hartmut
    Quach, Hang
    Mohty, Mohamad
    Venner, Christopher P.
    Weisel, Katja
    Raje, Noopur
    Hebraud, Benjamin
    Belhadj-Merzoug, Karim
    Benboubker, Lotfi
    Decaux, Olivier
    Manier, Salomon
    Caillot, Denis
    Ukropec, Jon
    Pei, Huiling
    Van Rampelbergh, Rian
    Uhlar, Clarissa M.
    Kobos, Rachel
    Zweegman, Sonja
    [J]. LEUKEMIA, 2022, 36 (04) : 1066 - 1077
  • [37] Incidence, Timing, and Management of Infections in Patients Receiving Daratumumab for the Treatment of Newly Diagnosed Transplant-Ineligible Multiple Myeloma in the MAIA Study
    Bahlis, Nizar J.
    Facon, Thierry
    Usmani, Saad
    Moreau, Philippe
    Raje, Noopur
    Zweegman, Sonja
    Chari, Ajai
    Perrot, Aurore
    Manier, Salomon
    Orlowski, Robert
    Goldschmidt, Hartmut
    Basu, Supratik
    Hulin, Cyrille
    Weisel, Katja
    Mohty, Mohamad
    Plesner, Torben
    Cook, Gordon
    Leleu, Xavier
    Quach, Hang
    Venner, Christopher P.
    Ngo, Mai
    Bolyard, Kasey
    Carson, Robin
    Borgsten, Fredrik
    Kumar, Shaji
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S221 - S221
  • [38] Daratumumab, lenalidomide, and dexamethasone in Japanese patients with transplant-ineligible newly diagnosed multiple myeloma: a phase 1b study
    Takamatsu, Hiroyuki
    Iida, Shinsuke
    Shibayama, Hirohiko
    Shibayama, Kazuhiro
    Yamazaki, Hiroshi
    Suzuki, Kenshi
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (05) : 692 - 701
  • [39] Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
    Thierry Facon
    Gordon Cook
    Saad Z. Usmani
    Cyrille Hulin
    Shaji Kumar
    Torben Plesner
    Cyrille Touzeau
    Nizar J. Bahlis
    Supratik Basu
    Hareth Nahi
    Hartmut Goldschmidt
    Hang Quach
    Mohamad Mohty
    Christopher P. Venner
    Katja Weisel
    Noopur Raje
    Benjamin Hebraud
    Karim Belhadj-Merzoug
    Lotfi Benboubker
    Olivier Decaux
    Salomon Manier
    Denis Caillot
    Jon Ukropec
    Huiling Pei
    Rian Van Rampelbergh
    Clarissa M. Uhlar
    Rachel Kobos
    Sonja Zweegman
    [J]. Leukemia, 2022, 36 : 1066 - 1077
  • [40] A Phase II Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVD lite) for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
    O'Donnell, Elizabeth
    Laubach, Jacob P.
    Yee, Andrew J.
    Huff, Carol Ann
    Basile, Frank
    Wade, Philip M.
    Paba-Prada, Claudia E.
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Couture, Nicole
    Doherty, Lauren
    Lyons, Hannah
    English, Caroline
    Munshi, Nikhil
    Anderson, Kenneth C.
    Richardson, Paul G.
    Raje, Noopur
    [J]. BLOOD, 2014, 124 (21)